ACIP, MMRV, and Vaccine Equity—What the September 2025 Vote Did Not Ask - Summary - MDSpire

ACIP, MMRV, and Vaccine Equity—What the September 2025 Vote Did Not Ask

  • By

  • Elizabeth L. Cope

  • Aaron E. Carroll

  • July 10, 2026

  • 0 min

Share

Objective:

To analyze the implications of the September 2025 ACIP vote to remove MMRV as an option for children under 4 years and its impact on vaccine accessibility.

Approach:
  • Population Analysis: Examination of MMRV usage among children in King County, highlighting demographic disparities and access issues.
  • Policy Review: Assessment of the ACIP voting process and its adherence to established evidentiary frameworks.
Key Findings:
  • 15% of children under 4 in King County received MMRV, with higher rates among minority groups and those eligible for the VFC program.
  • The September 2025 ACIP vote lacked a comprehensive Evidence-to-Recommendations analysis.
  • Procedural safeguards historically ensuring ACIP's independence were absent during the vote.
  • The vote disproportionately reduced access to MMRV for families reliant on federal recommendations.
Interpretation:

The procedural shortcomings in the ACIP's decision-making process raise concerns about the equity and transparency of vaccine policy changes.

Limitations:
  • Data is from a single county and may not represent broader trends.
  • Potential equity implications in less resourced settings are not fully explored.
Conclusion:

The removal of MMRV as a vaccination option narrows access for vulnerable populations, undermining previous achievements in reducing vaccination disparities.

Sources:

Original Source(s)

Related Content